3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Prostatic Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Carcinoma, Hepatocellular
15
Brain Neoplasms
12
Breast Neoplasms
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Lung Neoplasms
5
Neoplasms
4
Recurrence
3
Colorectal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroma, Acoustic
2
NSCLC
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Esophageal Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Stage IA - IB Non Small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Spine Metastasis
1
Spinal Neoplasms
1
Spinal Bone Metastases
1
Solid Tumor
1
Sarcoma
1
Rare Diseases
1
Radiotherapy
1
Interventions
Dexmedetomidine
3
Saline Solution
2
Hydrocortisone
2
parecoxib
1
loxoprofen
1
lanreotide
1
Visual Field Tests
1
Visual Acuity
1
Transcranial Magnetic Stimulation
1
Tramadol
1
Temozolomide
1
TBR-760
1
Surgical Procedures, Operative
1
Solutions
1
Sodium Chloride
1
Sevoflurane
1
Rosiglitazone
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy
1
Radiosurgery
1
Propofol
1
Prednisone
1
Positron-Emission Tomography
1
Nasal Lavage
1
Magnetic Resonance Spectroscopy
1
Injections
1
Fluorodeoxyglucose F18
1
Early Intervention, Educational
1
Diffusion Tensor Imaging
1
Desflurane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pituitary Neoplasms
×
Radiosurgery
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled